ConductScience.org, home

Library / Genes

LAMP2: lysosome associated membrane protein 2

1 protein, 127 patents, 0 drugs, 0 trials, 3,503 NIH grants and 5,664 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolLAMP2HGNC
Namelysosome associated membrane protein 2HGNC
NCBI Gene ID3920NCBI Gene
HGNC IDHGNC:6501HGNC
EnsemblENSG00000005893NCBI Gene
AliasesCD107b, DND, LAMP-2, LAMPB, LGP-96, LGP110NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P13473Lysosome-associated membrane glycoprotein 24102Ensembl, GeneID, HGNCUniProt

Patents 127

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4824266 A12026-10-2160P13473Espacenet
EP 4773979 A12026-07-15180P13473Espacenet
JP 2026067851 A2026-04-21286P13473Espacenet
JP 2026050416 A2026-03-1910P13473Espacenet
US 12564647 B22026-03-03214P13473Espacenet
JP 2026004568 A2026-01-1452158P13473Espacenet
JP 2025174969 A2025-11-284P13473Espacenet
EP 4650780 A22025-11-19208P13473Espacenet
JP 2025160297 A2025-10-222P13473Espacenet
JP 2025529142 A2025-09-042335P13473Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3503

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant202,025NIH's project files
R01GM083144Characterization of mammalian COG complex-interacting Golgi trafficking machinery152,025NIH's project files
P30CA008748Cancer Center Support Grant112,025NIH's project files
P20GM121176Autophagy, Inflammation and Metabolism (AIM) in Disease Center - Phase 2.92,025NIH's project files
P30CA013330Cancer Center Support Grant92,025NIH's project files
ZIAHG200336Genetic and clinical studies of Gaucher disease and other lysosomal disorders92,025NIH's project files
P30CA016059Massey Cancer Center - Cancer Center Support Grant82,025NIH's project files
P30DK020579Diabetes Research Center82,025NIH's project files
P30CA010815Consolidated Basic Cancer Research Program72,025NIH's project files
P30CA014051Cancer Center Support (Core) Grant72,025NIH's project files

Papers 5664

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42817668PubTator, text miningPubMed
42798645PubTator, text miningPubMed
42793309PubTator, text miningPubMed
42776282PubTator, text miningPubMed
42776111PubTator, text miningPubMed
42744597PubTator, text miningPubMed
42627451PubTator, text miningPubMed
42626968PubTator, text miningPubMed
42594829PubTator, text miningPubMed
42590185PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license